Evidence map›Paper›PMID 40574051›Full record

ArticlePharmaceutics2025

Maria-Roxana Tudoroiu-Cornoiu, Radu Marian Șerban, Diana Cocioabă, Dragoș Andrei Niculae, Doina Drăgănescu, Radu Leonte, Alina Catrinel Ion, Dana Niculae

Abstract read
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maria-Roxana Tudoroiu-CornoiuRadiopharmaceutical Research Centre (CCR), Horia Hulubei National Institute for R&D in Physics and Nuclear Engineering (IFIN-HH), 30 Reactorului Street, 077125 Măgurele, Romania.ORCID 0000-0001-7886-9900
Radu Marian ȘerbanRadiopharmaceutical Research Centre (CCR), Horia Hulubei National Institute for R&D in Physics and Nuclear Engineering (IFIN-HH), 30 Reactorului Street, 077125 Măgurele, Romania.
Diana CocioabăRadiopharmaceutical Research Centre (CCR), Horia Hulubei National Institute for R&D in Physics and Nuclear Engineering (IFIN-HH), 30 Reactorului Street, 077125 Măgurele, Romania.ORCID 0000-0002-0445-0581
Dragoș Andrei NiculaeRadiopharmaceutical Research Centre (CCR), Horia Hulubei National Institute for R&D in Physics and Nuclear Engineering (IFIN-HH), 30 Reactorului Street, 077125 Măgurele, Romania.
Doina DrăgănescuFaculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6 Traian Vuia Street, 020956 Bucharest, Romania.
Radu LeonteRadiopharmaceutical Research Centre (CCR), Horia Hulubei National Institute for R&D in Physics and Nuclear Engineering (IFIN-HH), 30 Reactorului Street, 077125 Măgurele, Romania.ORCID 0000-0002-2929-8280
Alina Catrinel IonFaculty of Chemical Engineering and Biotechnologies, Doctoral School of Applied Chemistry and Materials Science, National University of Science and Technology Politehnica Bucharest, 1-7 Gheorghe Polizu Street, 011061 Bucharest, Romania.
Dana NiculaeRadiopharmaceutical Research Centre (CCR), Horia Hulubei National Institute for R&D in Physics and Nuclear Engineering (IFIN-HH), 30 Reactorului Street, 077125 Măgurele, Romania.ORCID 0000-0002-4769-843X

Funding

International Atomic Energy Agency CRP F22071, Contract 23375Romanian Ministry of Research, Innovation and Digitalization PN23210201
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

affibodybreast cancerHER2-positivepharmacokineticsradiopharmaceuticalszirconium-89

Identifiers

PMID40574051
PMCPMC12196019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.